摘要
为控制替格瑞洛的产品质量和进行药物体内代谢研究,合成了替格瑞洛的两种代谢物,AR-C133913XX[化学名:(1S,2S,3R,5S)-3-[7-氨基-5-丙硫基-3H-1,2,3-三唑并[4,5-d]嘧啶-3-基]-5-(2-羟乙氧基)环戊烷-1,2-二醇]和ARC124910XX[化学名:(1S,2R,3S,4R)-4-[7-[(1R,2S)-2-(3,4-二氟苯基)环丙胺基]-5-丙硫基-3H-1,2,3-三唑[4,5-d]嘧啶-3-基]环戊烷-1,2,3-三醇],并通过核磁、质谱对其进行结构确证。
To perform the quality control of ticagrelor and study the metabolic pathway of the drug in vivo, two metabolites of ticagrelor, AR-C 133913XX [ ( 1S,2S,3R,5S) -3- E7-amino-5-propylthio-3H- 1,2,3-triazolo [4,5-d] pyrimidin- 3-yl) -5- (2-hydroxyethoxy) cyclopentane- 1,2-diol] and AR-C 124910XX [ (1S,2R,3S,4R) -4- [7- [ (1R,2S) -2- (3,4-difluorophenyl) cyclopropylamino] -5 -propylthio-3H- 1,2,3-triazolo [4,5-d] pyrimidin-3-yl]cyclopentane- 1,2,3-triol] were prepared. Their structures were confirmed by NMR and ESI-MS.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2016年第12期1503-1507,共5页
Chinese Journal of Pharmaceuticals
关键词
替格瑞洛
代谢物
有关物质
合成工艺
ticagrelor
metabolite
related substance
synthesis process